stockrow
Friday 6 November 2026
Export STE’s income statement to Excel — free account
STERIS plc
STE Healthcare Medical Devices
STERIS plc’s revenue for fiscal 2026 (year ended March 2026) was $5.9 billion, up 8.73% from fiscal 2025.
- Revenue
- +8.79%
- EPS
- +12.8%
- Free cash flow
- +43.6%
- Total debt
- −0.21%
Quarter to September 2026, against a year earlier
252.70
1.42
−0.56%
Follow STE
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 From the 10-Q filed 5 Nov | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
10.41% | 11.33% | 11.35% | 11.57% | |
Piotroski F-Score |
9 | 9 | 8 | 8 | |
| 6.87% | 7.49% | 7.62% | 7.83% | ||
ROIC |
7.24% | 7.92% | 8.27% | 8.47% | |
Return on Tangible Assets |
20.24% | 22.94% | 24.14% | 23.90% | |
Average Days of Receivables |
62.04 | 67.20 | 61.25 | 59.51 | |
Free Cash Flow per Share |
9.54 | 10.01 | 9.59 | 13.25 | |
Free Cash Flow |
936.70 | 982.90 | 936.00 | 1,289.70 | |
Capital Expenditures |
(330.10) | (358.50) | (352.50) | — | |
| Other line items | |||||
Cash ROIC |
9.87% | 10.27% | 9.75% | 13.30% | |
Accounts Receivable Turnover |
6.12 | 5.56 | 6.16 | 6.32 | |
Accounts Payable Turnover |
12.45 | 10.68 | 10.40 | 10.63 | |
Inventory Turnover |
4.92 | 5.46 | 4.96 | 4.90 | |
Average Days of Payables |
31.94 | 37.37 | 37.44 | 35.69 | |
Days of Inventory on Hand |
75.46 | 69.68 | 77.48 | 78.70 | |
Tax Rate |
(0.24) | (0.25) | (0.26) | (0.26) | |
Research and Development Expense of Revenue |
1.92% | 1.90% | 1.91% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
23.84% | 23.72% | 23.58% | 23.35% | |
Share Based Compensation of Revenue |
1.01% | 1.04% | 1.04% | 1.02% | |
Interest Coverage |
15.94 | 18.15 | 18.84 | — | |
Operating CF/Net income |
1.79 | 1.71 | 1.60 | 1.56 | |
Depreciation/Fixed assets |
0.23 | 0.23 | 0.23 | 0.23 | |
Capex/Depreciation |
(0.68) | (0.74) | (0.72) | 0.00 | |
Revenue per Share |
59.35 | 60.45 | 61.86 | 63.37 | |
Operating CF per Share |
12.90 | 13.66 | 13.20 | 13.25 | |
Capex per Share |
(3.36) | (3.65) | (3.61) | 0.00 | |
Capex to Sales |
0.06 | 0.06 | 0.06 | 0.00 |
Columns are period end dates · fundamentals updated 5 Nov 2026